We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Beam Therapeutics unveiled BEAM-101 trial data at ASH, showing improved outcomes in sickle cell patients and promising preclinical BEAM-103 results. Cathie Wood, CEO of ARK Invest, is doubling ...

One stock that might be an intriguing choice for investors right now is Beam Therapeutics Inc. BEAM This is because this ...

Check the time stamp on this data. Updated AI-Generated Signals for Beam Therapeutics Inc. (BEAM) available here: BEAM. Type a few symbols and Take a Trial. The signals for these will appear ...

Beam Global (NASDAQ:BEEM – Get Free Report) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 1,210,000 shares, an increase ...